PharmaCielo Ltd. (TSXV:PCLO)


Pharmacielo Ltd cultivates, produces, and develops cannabis products for medical purposes.

The firm’s common stocks are traded on the junior trading platform the TSX Venture Exchange. The trading symbol is ‘PCLO’.

The Toronto-based pharma company is primarily engaged in the production and distribution of cannabidiol (CBD), and tetrahydrocannabinol (THC) based extracts. It provides these under two distinct product lines: psychoactive and non-psychoactive products.

Psychoactive products are designed for medical healthcare segment and includes:
• THC Distillate
• THC: CBD Standardized Oil for therapeutic requirements

The pharma company claims non-psychoactive products are mostly commonly used in topical, capsules, tinctures, beverages and food.

It caters to customers in medical, wellness and nutraceutical health care sector.

The product offerings under the segment includes:
• Broad-Spectrum Distillate Standardized Oil
• CBD Isolate
• Broad-Spectrum Distillate
• Broad-Spectrum Oil
• Water Soluble CBD
• CBD Standardized Oil
• Full Spectrum Standardized Oil

Since 2016, PharmaCielo Ltd claims to hold a licensed by the Colombian Government to produce and market the medical grade cannabis (CBD and THC) extracts.

PharmaCielo owns integrated cultivation and extraction facilities that are technological advanced and backed up by research and development, reportedly.

The pharmaceutical company has business operations in Colombia, Italy, Mexico, and Canada. The Toronto-based company claims to earn a significant revenue from sales and distribution operations in Colombia.

In April 2021, PharmaCielo Ltd announced to deliver an initial shipment to two clients in Brazil as per the compliance requirements of Brazilian GMP standards.

Further on June 15, 2021, PharmaCielo Ltd announced the delivery of first shipment of CBD Isolate to a Canada-based life science company, whose name is kept undisclosed. Both companies are expected to work together to advance and develop drug delivery system in a bit to enhance and integrate the business-to-business value chain.

The drug manufacturing company also trades on the OTCQX Market under the stock symbol ‘PCLOF’.

Contact Information

company address 1 Toronto Street, Suite 805 Toronto, Ontario M5C 2V6

company phone647 272-9242

company email[email protected]

company website

Similar Companies

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK